New Weight Loss Supplement Alli Proving Popular
The New York Times reports that Alli has been selling briskly since first introduced a few months ago:
Desperate for a cure for fat, consumers have purchased more than two million starter packages of the new weight-loss product Alli since it was introduced four months ago.
Sales of the product, at $60 for each 90-pill package, met expectations of the maker GlaxoSmithKline, the company said yesterday. Alli, an over-the-counter version of the diet drug Xenical from Glaxo, is the first government-approved weight-loss drug available without a prescription. The company has predicted that five million to six million people a year will use Alli.
“The information we have about product satisfaction is very encouraging and very strong,” said Steven L. Burton, vice president, weight control products, for the consumer health care division of Glaxo. “About 70 percent of people reported losing weight.”